4//SEC Filing
CAIN CHRISTOPHER W. 4
Accession 0000950170-25-082368
CIK 0001622229other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:24 PM ET
Size
6.0 KB
Accession
0000950170-25-082368
Insider Transaction Report
Form 4
CAIN CHRISTOPHER W.
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-04+44,700→ 44,700 totalExercise: $5.64Exp: 2035-06-04→ Common Stock (44,700 underlying)
Footnotes (2)
- [F1]This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2026 Annual Meeting of Stockholders.
- [F2]Under the Reporting Person's arrangement with Fairmount Funds Management LLC (the "Adviser"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a "Fairmount Fund"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.
Documents
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001817733
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:24 PM ET
- Size
- 6.0 KB